000 01618 a2200433 4500
005 20250516034041.0
264 0 _c20110915
008 201109s 0 0 eng d
022 _a1473-4877
024 7 _a10.1185/03007995.2011.576238
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSignorovitch, James E
245 0 0 _aComparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trials.
_h[electronic resource]
260 _bCurrent medical research and opinion
_cJun 2011
300 _a1263-71 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aDasatinib
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xdrug therapy
650 0 4 _aMale
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aPyrimidines
_xtherapeutic use
650 0 4 _aThiazoles
_xtherapeutic use
650 0 4 _aTreatment Outcome
700 1 _aWu, Eric Q
700 1 _aBetts, Keith A
700 1 _aParikh, Kejal
700 1 _aKantor, Evan
700 1 _aGuo, Amy
700 1 _aBollu, Vamsi K
700 1 _aWilliams, Denise
700 1 _aWei, L J
700 1 _aDeAngelo, Daniel J
773 0 _tCurrent medical research and opinion
_gvol. 27
_gno. 6
_gp. 1263-71
856 4 0 _uhttps://doi.org/10.1185/03007995.2011.576238
_zAvailable from publisher's website
999 _c20788952
_d20788952